Adagio Medical (NASDAQ:ADGM) Posts Earnings Results, Beats Estimates By $2.27 EPS

Adagio Medical (NASDAQ:ADGM – Get Free Report) announced its earnings results on Monday. The company reported ($5.13) earnings per share for the quarter, beating the consensus estimate of ($7.40) by $2.27, reports.

Adagio Medical Stock Down 1.2%

Shares of NASDAQ:ADGM traded down $0.02 during midday trading on Monday, reaching $1.91. The company had a trading volume of 6,041 shares, compared to its average volume of 105,540. The company has a debt-to-equity ratio of 4.00, a current ratio of 1.41 and a quick ratio of 1.15. The stock’s fifty day moving average price is $6.41 and its 200-day moving average price is $21.21. The stock has a market capitalization of $52.80 million, a P/E ratio of -0.04 and a beta of 0.07. Adagio Medical has a one year low of $1.50 and a one year high of $50.70.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded shares of Adagio Medical from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, August 19th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $105.00.

Read Our Latest Stock Analysis on ADGM

About Adagio Medical

(Get Free Report)

Adagio Medical is a medical technology company developing catheter-based systems for treating cardiac arrhythmias. Its technology uses ultra-low-temperature cryoablation, which applies very cold temperatures to create lesions in heart tissue that can interrupt abnormal electrical signals. The company’s platform includes the vCLAS system, designed for ventricular arrhythmias such as ventricular tachycardia, and the iCLAS system, designed for atrial fibrillation. These systems are intended for use in catheter ablation procedures by cardiac electrophysiology teams.

Featured Articles

Earnings History for Adagio Medical (NASDAQ:ADGM)

Receive News & Ratings for Adagio Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adagio Medical and related companies with MarketBeat.com's FREE daily email newsletter.